Oncolytic herpes virus
id:
oncolytic-herpes-virus-200-16790488
title:
Oncolytic herpes virus
text:
Many variants of herpes simplex virus have been considered for viral therapy of cancer; the early development of these was thoroughly reviewed in the journal Cancer Gene Therapy in 2002. This page describes the most notable variants—those tested in clinical trials: G207, HSV1716, NV1020 and Talimogene laherparepvec. These attenuated versions are constructed by deleting viral genes required for infecting or replicating inside normal cells but not cancer cells, such as ICP34.5, ICP6/UL39, and ICP4
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Oncolytic_herpes_virus
date created:
date modified:
2023-12-20T14:01:02Z
main entity:
{"identifier":"Q16992171","url":"https://www.wikidata.org/entity/Q16992171"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/45/Herpes_simplex_virus_TEM_B82-0474_lores.jpg","width":639,"height":500}
fields total:
13
integrity:
14